Clinical Trial Update: Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1) [Phase 3]

View source ↗

Summary

Phase 3 trial update for an oral ferric iron therapy in iron deficiency anaemia associated with ulcerative colitis, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Iron-deficiency Anaemia
• Ulcerative Colitis

Drugs mentioned

• Oral ferric iron therapy

Snippet

Sponsor: Shield Therapeutics | Conditions: Iron Deficiency Anaemia, Inflammatory Bowel Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-08-03